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The transcriptional response to infection with the
bacterium Listeria monocytogenes (Lm) requires
cooperative signals of the type I interferon (IFN-I)-
stimulated JAK-STAT and proinflammatory NF-kB
pathways. Using ChIP-seq analysis, we define genes
induced in Lm-infectedmacrophages through syner-
gistic transcriptional activation by NF-kB and the
IFN-I-activated transcription factor ISGF3. Using the
Nos2 and IL6 genes as prime examples of this group,
we show that NF-kB functions to recruit enzymes
that establish histone marks of transcriptionally
active genes. In addition, NF-kB regulates transcrip-
tional elongation by employing the mediator kinase
module for the recruitment of the pTEFb complex.
ISGF3 has a major role in associating the core medi-
ator with the transcription start as a prerequisite for
TFIID and RNA polymerase II (Pol II) binding. Our
data suggest that the functional cooperation be-
tween two major antimicrobial pathways is based
on promoter priming by NF-kB and the engagement
of the core mediator for Pol II binding by ISGF3.
INTRODUCTION
Immune cells respond to microbial invaders such as the Gram-
positive intracellular bacterium Listeria monocytogenes (Lm)
with specialized gene expression profiles (Hamon et al.,
2006; McCaffrey et al., 2004). Initial sensing of the microbe
occurs by surface and endosomal Toll-like receptors (TLRs),
whereas Lms escape from endosomal confinement to the
cytoplasm causes the engagement of different cytoplasmic
receptors to detect infection (Kawai and Akira, 2009; Mancuso
et al., 2009; Sauer et al., 2011; Seki et al., 2002; Woodward
et al., 2010). Collectively, these pattern recognition receptors
(PRRs) activate an extensive network of signals, leading to
NF-kB activation and the interferon regulatory factor (IRF)-300 Cell Reports 12, 300–312, July 14, 2015 ª2015 The Authorsmediated synthesis of mRNA for type I interferons (IFN-I).
IFN-I synthesis takes place exclusively upon recognition of
cytosolic bacteria (O’Riordan and Portnoy, 2002; Stockinger
et al., 2002). When escape from the phagosome is impeded,
the NF-kB pathway is activated without IFN-I synthesis (Farlik
et al., 2010).
The IFN-I receptor complex causes the phosphorylation of
signal transducers and activators of transcription 1 (STAT1)
and STAT2 by the receptor-associated Janus tyrosine kinases
(JAK). The tyrosine-phosphorylated STATs form heterodimers
and associate with IRF9 to form a trimeric complex, inter-
feron-stimulated gene factor 3 (ISGF3). Depending on the pro-
moter, ISGF3 may be both necessary and sufficient for the
transcription of IFN-stimulated genes, or it may require input
from additional signaling pathways (Levy and Darnell, 2002).
A prominent example of a gene whose expression is strongly
enhanced upon stimulation by an additional pathway is Nos2,
which encodes inducible nitric oxide synthase (iNOS), a critical
component of antibacterial defense (Bogdan, 2001; Farlik et al.,
2010). In macrophages infected with Lm, IFN-I/ISGF3 and
NF-kB synergize to stimulate the production of iNOS. During
infection, NF-kB binds first to the Nos2 promoter, converting
the PRR signal into a transcriptional memory effect for the sub-
sequent IFN-I-dependent deposition of ISGF3. NF-kB is neces-
sary for the recruitment of TFIIH and pTEFb, the complexes
containing the RNA polymerase II (Pol II) kinases CDK7 and
CDK9, whereas ISGF3 is essential for binding of the general
transcription factor TFIID and Pol II (Farlik et al., 2010; Wienerr-
oither et al., 2014).
The transcriptionally active state of a gene requires chro-
matin remodeling and modification as well as the phosphoryla-
tion of serines (S) within the Pol II carboxy-terminal domain
(CTD). S5 phosphorylation by CDK7 is a prerequisite for pro-
moter clearance and mRNA 50 end processing, whereas
CDK9 phosphorylation of the CTD at S2 is essential for subse-
quent mRNA elongation. Many groups have reported that the
bromo and extra terminal (BET) family member Brd4 is involved
in pTEFb recruitment, tethering the complex to transcriptional
activators or acetylated histones or acting in the context of
superelongation complexes (SECs) (Brasier et al., 2011; Jang
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Figure 1. Genes Co-regulated by Type I
Interferons and the NF-kB Pathway in
Macrophages Exposed to Heat-Killed Liste-
ria and Type I IFN
(A) Scheme depicting the scientific question.
(B) BMDMs were treated with hkL, IFNb or a
combination of both for 4 hr. Gene microarrays
were performed, and selected genes showing
synergistic induction by both stimuli were vali-
dated by qPCR.
(C) The distribution of 127 genes that were syner-
gistically induced by hkL and IFN-I according
to ChIP-seq Pol II signals with respect to fold
change in microarray analysis. Values represent
means ± SE of three or more independent bio-
logical replicates.
*p < 0.05, **p < 0.01, ***p < 0.001.et al., 2005; Luo et al., 2012; Yang et al., 2005). pTEFb associ-
ation with the Nos2 promoter is unaffected by BET inhibition
(Wienerroither et al., 2014), so recruitment of pTEFb to the
Nos2 promoter takes place by a different mechanism.
The kinase module of the mediator provides an alternative
platform for pTEFb recruitment. The mediator is a multi-subunit
protein complex that bridges transcription factors with Pol II
and initiation and elongation factors (Conaway and Conaway,
2013; Malik and Roeder, 2010). Association with the kinase
module containing the subunits MED12, MED13, cyclinC
(CcnC), and CDK8 is dynamic and influenced by transcription
factors interacting with the mediator core (Conaway and Con-
away, 2013; Donner et al., 2010; Ebmeier and Taatjes, 2010;
Malik and Roeder, 2010). The presence of the kinase module
permits mediator association with transcriptional cofactors
such as pTEFb (Donner et al., 2010; Ebmeier and Taatjes,
2010). The MED26 subunit has also been proposed to play a
part in pTEFb binding. Takahashi and colleagues co-purified
pTEFb with a complex containing MED26 and subunits shared
with the SEC. The results suggest that the MED26-containing
complex exchanges promoter-bound TFIID for pTEFb (Takaha-
shi et al., 2011).
The interaction of the mediator and its kinase module with
STATs has been little studied (Jamieson et al., 2012). CDK8
has recently been shown to regulate the activity of STAT1 di-
mers (Bancerek et al., 2013). Serrat et al. (2014) found LPS to
enrich CDK8 at the Nos2 promoter, an effect enhanced by his-
tone deacetylase (HDAC) inhibition. Because HDAC inhibitors
suppress Nos2, the authors propose that CDK8 negatively reg-
ulates Nos2.
We used chromatin immunoprecipitation sequencing (ChIP-
seq) analysis to identify other genes that are subject to regulation
by both NF-kB and ISGF3 in Lm-infected cells. We examined the
role of the STAT and NF-kB pathways in the modification ofCell Reports 12, 300–promoter chromatin and the modification
of Pol II. We report essential roles for
different portions of the mediator com-
plex in the NF-kB-dependent deposition
of pTEFb and in the ISGF3-dependent
recruitment of Pol II. Our results providea mechanistic explanation for the interaction between the
STAT and NF-kB pathways in the response to infection.
RESULTS
Genome-wide Search for Genes Co-regulated by the
STAT and NF-kB Pathways
A recent microarray analysis indicated a significant number of
genes synergistically induced by IFN-I/STAT and other pathways
(Farlik et al., 2010). To further define this group of genes under
the experimental conditions used throughout this study, bone
marrow-derived macrophages (BMDMs) were treated with
heat-killed Listeria (hkL, non-STAT pathways activated), IFN-I
alone (only the IFN-I/STAT pathway activated), or both stimuli
together. Genes induced under these conditions in microarrays
were filtered for a synergy factor >2; i.e., amore than 2-fold higher
induction with both stimuli over the addition of each stimulus
alone. 42 genes were identified, fulfilling this criterion (Table S1),
and examples of these were validated by qPCR (Figure 1B). To
determinewhether synergistic inductionwith IFN-I reflected func-
tional cooperativity with the NF-kB pathway, BMDMs were sub-
jected to the same treatment, and chromatin immunoprecipitates
with STAT1, NF-kB p65, or Pol II antibodies were sequenced.
Around 1,200 genes had STAT1 and NF-kB bound above back-
ground levels within 50 kB of their annotated transcription start
sites (TSSs). A comparison with the microarray analysis is shown
in Figure 1C. 127 ‘‘synergy genes’’withNF-kBandSTAT1binding
sites were defined byR2-fold Pol II binding within the 50-kb pro-
moter region after hkL/IFN-I co-treatment compared with single
treatment. 36 of these contained NF-kB and STAT1 peaks within
500 base pairs (bps) upstream of the TSS, such as the IL6 gene
(Figure S1). 11 genes (blue segment in Figure 1C; Nos2, Il6,
Ccl7, Ccrl2, Cd83, Edn1, Il10, Il1rn, Il27, Slamf1, and Slc28a2)
showed a microarray synergy factor of >2, and 28 genes (orange312, July 14, 2015 ª2015 The Authors 301
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Figure 2. Global Analysis of STAT1 and NF-kB Binding and Detection of Novel Binding Sites in the Nos2 Upstream Region
(A) Scheme depicting the scientific question.
(B and C) Motif analysis of genomic sequences ChIPed (enriched) with (B) NF-kB p65 and (C) STAT1 antibodies. Shown at the bottom are the web logos of de
novo computed motifs by DAVID from our ChIP-seq data. Shown at the top are the web logos of motifs present in the JASPAR database. The p value is the
probability that the match between the two web logos occurred by random chance according to the null model, as computed by TOMTOM.
(D) Co-occurrence of STAT1 and NF-kB binding sites within 50 kB of TSSs of all genes (left), genes not synergistically induced by hkL/IFNb cotreatment (center),
or genes with synergistic cooperativity according to ChIP-seq pol II signals (right).
(legend continued on next page)
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segment) showed synergy factors between 1- and 2-fold. 22
genes showed no added value of the co-treatment (Figure 1C,
green segment), and 11 responded to one stimulus only (white
segment). Together, the data define a group of genes under the
synergistic control of the STAT and NF-kB pathways.
A search for overrepresented short motifs (Bailey et al., 2006)
in genomic regions enriched by ChIP with an NF-kB-reactive
antibody revealed as best hit a motif corresponding closely to
the NF-kB binding motif in the JASPAR database (Figure 2B;
Sandelin et al., 2004). For the STAT1-reactive antibody, the
best hit corresponded to the ISGF3 binding motif (interferon
stimulation response element [ISRE]; Figure 2C). Among genes
with significant STAT1 peaks in the 50-kb upstream region
(including gene coordinates), we found slightly more g interferon
activation sites (GASs) than ISRE motifs (59% and 53%, respec-
tively). Among genes with significant STAT2 peaks, we also
found 59% with GAS sites but more with ISRE sites (65%).
A genome-wide analysis of STAT1 and NF-kB peaks in genes
and the relationship to transcriptional activity is shown in Fig-
ure 2D and Table S2A. Venn diagrams indicate the individual or
combined occurrence of STAT1 and NF-kB binding sites within
50 kB upstream of a TSS, either for all genes (Figure 2D, left),
those that do not show synergy of Pol II binding after hkL +
IFNb treatment (center), and those that show synergistic Pol II as-
sociation (right). Of the genes that are synergistic, 42% have NF-
kBpeaks. Themajority of these (78%) also contain STAT1 peaks,
a highly significant overrepresentation (p = 1.97e-6; Table S2B).
The fraction of genes with STAT1 peaks in this group is larger
(65%), in keeping with the dominance of the Jak-STAT pathway
in the transcriptional response to IFN. Similarly, synergistic genes
are significantly enriched for peaks of both NF-kB and STAT1
jointly compared with all other genes (p = 2.2e-16; Table S2C).
Surprisingly,bindingofbothNF-kBandSTAT1 to theNos2pro-
moter sites mapped previously by transient transfection (Kleinert
et al., 2004) and ChIP (Farlik et al., 2010) was very weak. This in-
cludes an NF-kB site at 86/76 and an IFN response region
with imperfect ISRE sequences at 952/940 and 924/911
with respect to the TSS (contained within the Chr11:78915 kb–
78925 kb region in Figure 2E; the TSS corresponds to nucleotide
78920787). Stronger binding of both NF-kB and STAT1 occurred
approximately 30 kb upstream of theNos2 TSS (chr11:78870 kb–
78890 kb). A search for NF-kBandSTATbinding sites in theNos2
gene body and 50 kB upstream sequence based on position
weight matrices from the JASPAR database revealed consensus
NF-kB sequences slightly downstream of the TSS and two peaks
in the distal enhancer (marked with an asterisk in Figure 2E).
Furthermore, this algorithm identified ISREconsensus sequences
in two STAT1 peaks of the distal enhancer (see asterisks). At the(E) BMDMs were treated with hkL, IFNb, or a combination of both for 4 hr. For STA
the indicated antibodies (Pol II, NF-kB p65, and STAT1), followed by next-gene
results obtained for Nos2 are shown with a scale of mapped reads. Shaded area
and IFN response elements. Asterisks mark ChIP binding sites with coinciding NF
detailed information, see text.
(F–H) BMDMswere treated for 4 hr with a combination of hkL and IFNb (F) or for 2 h
binding (H) to proximal promoter regions containing the NF-kB site or the IFN-resp
by ChIP. In the distal region, a 240-bp fragment (chr11: 78886608–78886847) co
Values represent mean and SE of at least three independent biological replicatestringency set for this search, neither the upstream NF-kB
element nor the putative ISRE sequences at 952/940 and
924/911 showed up as consensus elements, consistent with
weak STAT1 binding. Furthermore, two consensus ISREs corre-
sponded to regions without any apparent STAT1 association.
Likewise, NF-kB consensus elements without corresponding
ChIP-seq peaks were found.
NF-kB, STAT1, and STAT2 binding to the distal enhancer was
confirmed by site-directed ChIP and found to be stronger than
binding to the promoter-proximal sites indicated above (Figures
2F–2H). The region amplified in the distal enhancer is within the
shaded area of Figure 2E and contains both NF-kB and STAT1
ChIP-seq peaks (corresponding to chr11:78886608–78886847
or 34179/33939 with respect to the TSS). Interestingly, the
IL6 promoter also contained a far upstream enhancer with
NF-kB and STAT1 binding sites (29940 kb–29950 kb in Fig-
ure S1), in agreement with a recent report (Qiao et al., 2013).
The control ISG Mx2 showed no p65 binding but a strong
STAT1 peak, whereas the NF-kB target control Nfkbia showed
a prominent promoter-proximal p65 binding site but no binding
of STAT1 (Figure S1).
Gene ontology (GO) analysis was performed using DAVID
(Jiao et al., 2012) on the 127 STAT1/NF-kB-p65 synergy genes.
Significantly enriched (p < 0.05) GO terms clustered into the
following categories: innate immune response, adaptive immune
response, apoptosis, regulation of immune response, part of
the extracellular region, and cytokine/chemokine activity (Table
S3). Analysis of the same gene group for Kyoto Encyclopedia
of Genes and Genomes (KEGG) pathways produced the Jak-
STAT pathway as the second-most overrepresented pathway
(Table S3), with many other genes being clearly linked to path-
ways relevant for innate immunity. In summary, these findings
indicate that the interaction between ISGF3 and NF-kB in tran-
scriptional control of functionally interlinked genes supports
cell-based innate immunity to bacterial infection.
Histone 4 Acetylation at the Nos2 Promoter Occurs via
NF-kB-Dependent HAT Recruitment
The Nos2 gene was further analyzed as a paradigm for the inter-
play of the IFN-I and NF-kB pathways in transcriptional regula-
tion. Critical findings were confirmed with the IL6 gene, another
member of the ‘‘synergy group.’’
Our first aim was to analyze histone modifications of active
promoters. First, global histone 4 acetylation (H4ac) after Lm
infection in nucleosomes proximal to the TSSwas examined (Fig-
ure 3B). Acetylation of histone 4 lysine 5 (H4K5), histone 4 lysine 8
(H4K8), histone 4 lysine 12 (H4K12), and histone 4 lysine 16
(H4K16) occurred after treatment of BMDMs with hkL alone (solidT1, ChIP treatment was with IFNb for 2 hr. Cells were processed for ChIP with
ration sequencing of the precipitate. Genome browser views of the ChIP-seq
s indicate the promoter-proximal region and distal enhancer-containing NF-kB
-kB or ISRE consensus sequences as identified bymotif search algorithms. For
r with IFNb (G and H). NF-kB p65 (n = 3) (F), STAT1 (n = 3) (G), and STAT2 (n = 5)
onsive regions or the shaded distal region indicated in Figure 2Ewasmeasured
ntaining ChIP peaks for both NF-kB and STAT1 was amplified.
s. *p < 0.05, **p < 0.01, ***p < 0.001, ns, not significant.
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Figure 3. Recruitment of Histone Modifiers
and the Establishment of Histone Modifica-
tions by Heat-Killed Listeria and IFNb
(A) Scheme depicting the scientific question. HMT,
histone methyl transferase.
(B) BMDMs were infected with Lm for the indicated
time, followed by ChIP with antibodies to acetyl-H4.
(C) BMDMs were treated with hkL for the indicated
time in the presence (dashed line) or absence
(solid line) of the IKKb inhibitor BI605906 (10 mM),
followed by ChIP with antibodies to the acetylated
H4 lysines H4K5ac, H4K8ac, H4K12ac, and
H4K16ac and amplification of the proximal Nos2
promoter, including the TSS.
(D) BMDMswere treated as described in (C) for 4 hr,
followed by ChIP with antibodies to the histone
acetyl transferases CBP, PCAF, and GCN5 (n = 3).
untr., untreated.
(E) BMDMs were infected with Lm for the indicated
time (n = 2). Deposition of the H3K4me3 mark at the
distal and proximal Nos2 promoter was determined
by ChIP.
(F and G) BMDMs were transfected with the indi-
cated siRNAs to inhibit the expression of essential
subunits of the Set1A-B, MLL1-2, or MLL3-4
methyltransferase complexes. Transfected cells
were treated with hkL + IFNb for 4 hr. The cells were
assayed for synthesis of Nos2 mRNA by qPCR
(n = 2) (F) and for the recruitment of Menin and Pol II
or the establishment of the H3K4me3 mark by ChIP
(n = 3) at the Nos2 promoter (G). The data in (G)
represent percent binding compared with cells
transfected with control (contr.) siRNA. H3 binding
was measured as a negative control.
(H–J) BMDMswere treated with hkL or IFNb for 4 hr.
H3K4me3 (n = 2) (H), Menin (n = 2) recruitment (J),
and H2B ubiquitination (n = 2) (K) were determined
by ChIP. All ChIP experiments with antibodies to a
histone modification were additionally normalized
to total histone 3 levels.
Values represent mean and SE of at least three
independent biological replicates. *p < 0.05, **p <
0.01, ***p < 0.001.lines in Figure 3C) andwas reduced by the simultaneous inhibition
of NF-kB activation by the IKKb inhibitor BI605906 (Figure 3C,
dashed lines). To identify histone acetyltransferases (HATs)
responsible for proximal promoter acetylation, hkL-induced bind-
ing of PCAF, CBP, and GCN5 was analyzed. PCAF and GCN5
showedvery lowenrichment,whereas robust, BI605906-sensitive
recruitment was observed for CBP (Figure 3D). The data demon-
strateNF-kB-dependentCBP recruitment at theNos2 and Il6 (Fig-
ure S2A) genes. They favor the hypothesis that active chromatin at
these genes in hkL-treated macrophages requires CBP activity,
not ruling out a contribution of other HATs.
NF-kB Signaling Causes the Appearance of the
H3K4me3 Chromatin Mark at the Proximal
Nos2 Promoter
Another hallmark of transcriptionally active genes is the deposi-
tion of a histone 3 lysine 4 trimethylation (H3K4me3) mark at304 Cell Reports 12, 300–312, July 14, 2015 ª2015 The Authorsnucleosomes close to the TSS. Reportedly, the Taf3 subunit
binds to H3K4me3 to aid TFIID binding (Lauberth et al., 2013;
Vermeulen et al., 2007). Lm infection induced H3K4me3
proximal to the Nos2 TSS and, weaker, at the proximal IFN
response region (Figure 3E). Mammalian H3K4me3 methylase
complexes are distinguished by, respectively, WDR82 (Set1
A-B/COMPASS-like), Menin (MLL1-2/COMPASS-like), or PTIP
subunits (MLL3-4/COMPASS-like; Shilatifard, 2012; Smith
et al., 2011). Small interfering RNA (siRNA)-mediated knock-
down of individual subunits revealed a prominent role of the
Menin-containing complex for transcriptional induction of
Nos2 and Il6 by hkL/IFNb treatment (Figure 3F; Figure S2B).
In contrast, expression of the NF-kB-independent ISGF3 target
Mx2 was suppressed by WDR82 siRNA but not by Menin
targeting (Figure S2C), suggesting activity of Set1 A-B/
COMPASS-like methyl tranferases. Menin siRNA decreased
both Menin binding and the H3K4me3 mark at the proximal
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Figure 4. CDK9 Recruitment by the Medi-
ator Kinase Module
(A) Scheme depicting the scientific question.
(B–D) BMDMs were treated with hkL or IFNb
or a combination of both, followed by ChIP
analysis with antibodies to CDK9 (B), CDK8 (C),
or CcnC (D).
(E and F) WT and Stat1/ BMDMs were treated
with hkL, IFNb, or a combination of both, for 4 hr
with and without 10 mM IKKb inhibitor BI605906
as indicated, followed by ChIP analysis with anti-
body to CDK8 and qPCR for the proximal Nos2
promoter, including the TSS.
(G) BMDMs were treated for 2 or 4 hr with hkL +
IFNb, followed by cell lysis and precipitation for
CDK8 protein. Samples were loaded on an SDS-
PAGE gel, and antibodies to CDK7 and CDK9
were used in a western blot to analyze the inter-
action with CDK8.
(H–K) Knockdown of MED18 or CcnC was per-
formed in BMDMs. (H) The cells were treated with
hkL and IFNb for 4 hr, followed by mRNA extrac-
tion and qPCR for Nos2 expression. Additionally,
cells were analyzed by ChIP with antibodies to
CDK9 (I), pS2Pol II (J), or Pol II (K). Enrichment fold
values at the proximal Nos2 promoter for the
control siRNA samples were as follows: CDK9,
2.7; pS2Pol II, 3.31; Pol II, 4.1.
Values represent means ± SE of three or more
independent biological replicates. *p < 0.05,
**p < 0.01, ***p < 0.001.Nos2 and IL6 promoters (Figure 3G; Figures S2D and S2E).
Consistently, the appearance of Menin and H3K4me3 showed
similar kinetics, and both were stimulated by hkL but not by
IFNb treatment (Figures 3H and 3I).
Monoubiquitination of H2B (H2Bub) is a frequent pre-
requisite for H3K4 trimethylation (Soares and Buratowski,
2013). Like Menin and H3K4me3, this modification was estab-
lished by hkL treatment alone, suggesting that the NF-kBCell Reports 12, 300–pathway mediates both H2Bub and
H3K4me3 modifications (Figure 3J). The
data therefore suggest that NF-kB re-
cruits the machinery for Nos2 and Il6
H3K4 trimethylation.
Mediator Kinase Module Recruits
CDK9 to the Nos2 Promoter
pTEFb/CDK9 association with the Nos2
promoter is Brd4-independent but re-
quires NF-kB (Wienerroither et al., 2014).
To identify the pTEFb/CDK9 recruitment
mechanism, pTEFb interaction with
CDK8 and the mediator kinase module
was examined (Donner et al., 2010). In
BMDMs, binding of CDK9 or of CDK8
and its regulatory subunit CcnC to a
region encompassing the Nos2 (Figures
4B–4E) or IL6 (Figure S3) TSS followed
the same pattern. It was stimulated byhkL, not by IFNb, and both stimuli together produced a slight,
statistically insignificant increase over hkL alone (Figures 4B–
4D; Figure S3). CDK8 binding was sensitive to IKKb inhibition
(Figure 4E) and largely unperturbed by Stat1 deficiency (Fig-
ure 4F). CDK8 binding to the Il6 gene was less robust but
occurred under the same conditions (Figure S4A). Consistent
with the presence of these proteins in a common complex,
CDK8 and CDK9 were co-immunoprecipitated from BMDM312, July 14, 2015 ª2015 The Authors 305
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Figure 5. Association of the Mediator Subunits MED1 and MED26
with the Nos2 Promoter
(A) Scheme depicting the scientific question.
(B–E) WT or Stat1/ BMDMs were treated with hkL, IFNb, or a combination of
both with or without 10 mM IKKb inhibitor for 4 hr. The cells were processed for
ChIP with antibodies to MED1 (B and C) or MED26 (D and E). Enrichment at the
proximal Nos2 promoter/TSS was analyzed by qPCR. Values represent
means ± SE of four or more independent biological replicates. *p < 0.05, **p <
0.01, ***p < 0.001.lysates, particularly after hkL/IFNb treatment (Figure 4G). The
lack of interaction between CDK7 and CDK8 is shown as a
control.
CcnC siRNA and, as a control, MED18 siRNA were used to
verify the importance of the CDK8/CcnC pair for CDK9 recruit-
ment. Both CcnC and MED18 siRNAs caused an approximately306 Cell Reports 12, 300–312, July 14, 2015 ª2015 The Authors50% reduction of Nos2 mRNA induction by combined hkL/IFNb
treatment (Figures 4H and S4B). Consistent with a role of CDK8/
CcnC in CDK9 recruitment, CcnC siRNA, but not MED18 siRNA,
reduced CDK9 association with Nos2 in hkL/IFNb-treated
BMDMs (Figure 4I). Accordingly, CcnC knockdown specifically
abrogated S2 phosphorylation of the Pol II CTD (Figure 4J). By
contrast, MED18 siRNA, but not CcnC siRNA, reduced the bind-
ing of Pol II to the Nos2 TSS (Figure 4K). The results obtained for
the IL6 gene were in agreement with those for Nos2 (Figures
S4C–S4E). Our data support the notion that the mediator kinase
module is required for pTEFb association with the Nos2 and Il6
promoters. They are in line with recent findings showing a
requirement of CDK8 for pTEFb recruitment, but not CDK7
(TFIIH) recruitment, at hypoxia-inducible genes (Galbraith et al.,
2013).
Concerted Action of the STAT and NF-kB Pathways in
Mediator Recruitment
Our results show that NF-kB recruits histone-modifying en-
zymes, Pol II kinases, and the mediator kinase module. By
contrast, IFN-I and ISGF3 are necessary for TFIID and Pol II
binding (Farlik et al., 2010). The STAT1 as well as STAT2 sub-
units of the ISGF3 complex interact functionally and physically
with the mediator (Lau et al., 2003; Zakharova et al., 2003).
Because the mediator bridges the initiation complex with tran-
scriptional activators, we examined the contribution of the
STAT and NF-kB pathways to its association with the Nos2
promoter.
We first determined the presence of the MED1 and MED26
subunits because these do not always co-purify with the core
mediator (Malik and Roeder, 2010). Particularly MED26-contain-
ing mediators are suggested to function without the kinase
module, possibly as an alternative recruitment mechanism for
pTEFb (Conaway andConaway, 2013; Donner et al., 2010; Taka-
hashi et al., 2011). Both MED1 and MED26 associated with
the Nos2 promoter in response to stimulation of BMDMs with
hkL/IFNb (Figures 5B and 5D). LessMED1 binding occurred after
stimulation with hkL and none after IFNb treatment alone. Bind-
ing was sensitive to IKKb inhibition (Figure 5B) but resisted Stat1
deficiency (Figure 5C). The IL6 gene showed a similar behavior
toward MED1, although binding was less robust (Figure S4F).
MED26 bound weakly to the Nos2 TSS after IFNb treatment
alone, whereas induction by hkL was marginal. MED26 resisted
IKKb inhibition but was entirely lost in Stat/ macrophages
(Figures 5D and 5E). STAT1-dependent MED26 recruitment,
therefore, differs strikingly not only from MED1 but also from
the conditions of pTEFb/CDK9 promoter binding (Figure 4F),
ruling out a role of MED26 in tethering pTEFb to the Nos2
promoter.
The data suggest that Lm signaling recruits a mediator,
including MED1, MED26, and the kinase module, to the Nos2
promoter through NF-kB-ISGF3 cooperativity. To determine
whether this extends to subunits of the core mediator, binding
of the tail subunit MED5/24was examined. As forMED26 recruit-
ment, binding was lost in Stat1/ cells but maximally induced
with STAT and NF-kB signaling together (Figures 6B and 6C).
Similarly, binding of MED18, a subunit of the mediator head,
required STAT1 (Figures 6D and 6E). At the IL6 promoter,
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Figure 6. Nos2 Promoter Binding of the Core Mediator
(A) Scheme depicting the scientific question.
(B–L) WT, Stat1/, or Stat2/ BMDMs were treated with hkL, IFNb, or a combination of both with or without 10 mM IKKb inhibitor BI605906 for 4 hr. The cells
were processed for ChIP with antibodies toMED5/24 (B, C, and K), MED18 (D, E, and J), MED4 (F and G), MED7 (H and I), or CDK8 (L). Enrichment at the proximal
Nos2 promoter/TSS was analyzed by qPCR. Values represent means ± SE of four or more independent biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 7. Model Describing the Regulation
of the Nos2 Gene in Listeria monocyto-
genes-Infected Macrophages by the STAT
and NF-kB Pathways
NF-kB association with the Nos2 promoter is
the initial step and delivers histone-modifying en-
zymes (CBP andMLL1/MLL2 COMPASS-like) that
produce transcription-friendly chromatin. NF-kB
also recruits TFIIH/CDK7 and pTEFb/CDK9, the
kinases required for Pol II phosphorylation. NF-kB-
dependent stable binding of TFIIH/CDK7 is
achieved with the help of the BET protein Brd4.
pTEFb/CDK9 is recruited to the promoter via the
mediator kinase module, which, like MED1, asso-
ciates in complete dependence on NF-kB. By
contrast, ISGF3 binding is essential for the for-
mation of a pre-initiation complex, particularly the
binding of TFIID. ISGF3 also provides a critical
contribution to the acquisition of the core mediator
and Pol II. For a further explanation, see the text
and accompanying references.MED18 binding displayed a similar behavior although less
dependence on NF-kB signaling. Again, enrichment was less
robust as that seen for Nos2 (Figures S4G and S4H).
The subunits of the mediator middle domain, MED4 and
MED7, differed from the head and tail domains by their stronger
dependence on NF-kB for binding to the Nos2 TSS. Association
was stimulated by hkL treatment alone and reduced by the IKKb
inhibitor (Figures 6F and 6H). However, input from IFN signaling
was confirmed in Stat1/ cells and by a low level of MED4 and
MED7 association after IFNb treatment alone (Figures 6F–6I).
Mediator core recruitment to the Nos2 promoter in Stat2/
macrophages was essentially as in Stat1/ cells. The MED18
and MED5/24 subunits were missing, but the kinase/CDK8 mod-
ule was present after hkL/IFNb treatment (Figures 6J–6L). The
simultaneous presence of the mediator and ISGF3 at the Nos2308 Cell Reports 12, 300–312, July 14, 2015 ª2015 The AuthorspromoterwasascertainedbyChIP-reChIP
analysis (Farlik et al., 2010; Figure S5).
Both STATs were re-precipitated from
MED18/MED5/24 ChIPs and, vice versa,
the MED subunits from STAT1/2 ChIPs.
Mx2 and IkBa were used, respectively,
as IFNb/ISGF3 and hkL/NF-kB control
genes (Figure S6). Unlike Nos2 and IL6,
all tested mediator subunits associated
with their respective stimulus alone,
although CDK8 at the Mx2 promoter
was increased further by combined hkL
treatment. Our data support the idea
that genes showing NF-kB/ISGF3 coop-
eration require both transcription factors
to associate with a complete mediator
complex.
DISCUSSION
Higher eukaryotes must be able to
respond rapidly to changing environ-mental conditions or challenges such as invading micro-
organisms. Transcriptional gene activation is an indispensable
component of the complex cellular response to microbial infec-
tion. We studied the case of Lm infection, focusing on transcrip-
tional synergism by NF-kB and ISGF3, transcription factors at
the endpoints of two major antimicrobial pathways. Our work
reveals that different portions of the mediator complex are
involved in the NF-kB-dependent binding of pTEFb and in the
ISGF3-dependent recruitment of Pol II to gene promoters. We
are therefore able to provide a mechanistic explanation for the
interaction between the two pathways (Figure 7).
In the early phase of infection, before IFN-I is produced, NF-kB
delivers histone-modifying enzymes that produce transcription-
friendly chromatin. Although the strongest acetyl transferase
signal was obtained for CBP binding, an involvement of other
HATs cannot be excluded from these findings. NF-kB also man-
ages the acquisition of the Pol II CTD kinases (Farlik et al., 2010),
and Brd4 helps stabilize binding of TFIIH/CDK7 to the promoter
of the iNOS gene (Wienerroither et al., 2014). pTEFb/CDK9 are
brought in via the mediator kinase module (Figures 4G–4K). At
a later stage, signaling by the IFN-I receptor causes ISGF3 bind-
ing, which is essential for the acquisition of the core mediator
(Figure 6), TFIID (Farlik et al., 2010), and Pol II (Farlik et al.,
2010). Interestingly, recruitment of pTEFb/CDK9 by NF-kB
draws upon the mediator kinase module before the core is
recruited with the help of ISGF3. Deposition of the kinases
needed for both promoter clearance and elongation prepares
Nos2-coregulated promoters for immediate firing in response
to the second activating signal, which is provided by IFN-I/
ISGF3. It seems unlikely that such a sophisticated mechanism
would be unique to a single gene (Nos2). Indeed, we confirmed
key results with the Nos2-like IL6 gene.
A detailed examination of the chromatin modifications associ-
ated with transcriptionally active chromatin revealed H4 acetyla-
tion and H3K4me3 at nucleosomes proximal to the TSS. The
modifications are the result of the modifying enzyme CBP and
the MLL1-2/COMPASS-like complexes, which associate with
the Nos2 promoter in the absence of IFN-I. Menin/MLL1-2
methyltransferase complexes are known to regulate a number
of cellular genes, including Hox genes and other genes important
for development (Wang et al., 2009). We now show that MLL1-2
also has a role in the innate immune response.
The H2Bub and H3K4me3 marks at the Nos2 and Il6 genes
appear prior to the ISGF3-dependent recruitment of Pol II
and depend solely on the NF-kB pathway. In contrast, initial
recruitment of the yeast complex containing the Set H3K4
methyltransferase occurs by the Pol II-associated PAF com-
plex, and transcription is required for H2B ubiquitination as
well as for H3K4me3 catalysis. Reportedly, H3K4 trimethylation
enhances transcriptional initiation through interaction with the
TFIID complex (Lauberth et al., 2013; Vermeulen et al., 2007).
It is attractive to speculate that NF-kB-dependent H3K4 trime-
thylation supports the ISGF3-dependent recruitment of TFIID
(Farlik et al., 2010), which would represent a further example
of crosstalk between the NF-kB and IFN pathways.
Phosphorylation of the Pol II CTD is essential for gene tran-
scription. In Lm-infected cells, the Nos2 promoter is occupied
by the TFIIH and pTEFb complexes as a result of NF-kB signaling
(Farlik et al., 2010; Wienerroither et al., 2014). CTD phosphoryla-
tion at both S5 and S2 occurs rapidly after promoter association
of Pol II, which depends on ISGF3. Although TFIIH persistence
requires the BET protein Brd4, pTEFb/CDK9 binding is indepen-
dent of Brd4 (Wienerroither et al., 2014) because the mediator
kinase module, particularly its CcnC/CDK8 subunits, is able to
recruit pTEFb to the Nos2 and IL6 promoters. Our conclusion
is based on the following three lines of evidence: the recruitment
conditions and kinetics of CcnC/CDK8 and CDK9 are strikingly
similar; antibody-mediated co-purification of CDK8 and CDK9
is possible in untreated macrophages and enhanced after
stimulation with hkL/IFNb; and siRNA-mediated knockdown of
CcnC selectively suppresses CDK9 binding and S2 phosphory-
lation of the Pol II CTD. The data are consistent with observations
of increased CDK8 association in LPS-treated macrophages(Serrat et al., 2014) and with previous findings on serum-respon-
sive genes (Donner et al., 2010; Ebmeier and Taatjes, 2010).
The MED26 subunit of the mediator has been implicated in the
recruitment of pTEFb to promoters (Takahashi et al., 2011). How-
ever, the conditions under which MED26 associated with the
Nos2 promoter were different from those under which pTEFb
associated. In addition, MED26 is believed to act by the ex-
change of TFIID and pTEFb, which is not compatible with the
deposition of pTEFb by the NF-kB pathway independently of
ISGF3-mediated TFIID association. It appears, therefore, that
the kinase module alone suffices for pTEFb binding. Neverthe-
less, recruitment of MED26 by IFN-I may partially explain the
enhancement of NF-kB-mediated CDK8 binding by the cytokine.
MED26 is not the only subunit of the core mediator to depend
on IFN-I for recruitment to the Nos2 and Il6 promoters. Recruit-
ment of all core subunits we investigated also requires IFN-I and
is, therefore, generally affected by Stat1 and Stat2 deficiency.
For example, MED5/24 and MED18 are not detected at the
Nos2 promoter in Stat1-deficient macrophages treated with a
combination of hkL and IFN-I, and a smaller amount of MED4
binds the Nos2 TSS under these conditions. Consistent with
the requirement for STAT1/2, subunits of the mediator core
were induced to various degrees to bind theNos2 promoter after
IFN-I treatment alone. The subunits of the middle portion of the
mediator, MED4 and MED7, revealed a significant input of
NF-kB signaling and were partially recruited by hkL treatment
alone. The data show that ISGF3 andNF-kB interact to assemble
a complete mediator at the Nos2 TSS, with recruitment of the
kinase module and MED1 completely dependent on NF-kB
and recruitment of other subunits requiring STAT1, with various
degrees of input from NF-kB signaling.
Two mechanistic interpretations could account for the dual
requirement for ISGF3 and NF-kB. A preassembled mediator
might require tethering by both transcription factors, or the
mediator might be only partially preformed and require assembly
by concerted action in a promoter-specific context. The latter
interpretation is supported by studies showing that the compo-
sition of the mediator is determined by the interacting transcrip-
tion factors (Ebmeier and Taatjes, 2010; Poss et al., 2013) and
that about 30%of CDK8 exists independent of the coremediator
complex (Knuesel et al., 2009). It is further consistent with a
recent study in yeast that suggested a modular character of
the mediator complex (Paul et al., 2015).
Our mechanistic studies of the Nos2 and Il6 promoters are
relevant to a large number of genes. ChIP-seq targeting
STAT1, NF-kB, and Pol II has defined 127 genes that are bound
by both ISGF3 and NF-kB and that are expressed as a result of
synergy between the two pathways. The ChIP-seq data also
reveal that the major binding site for NF-kB (and ISGF3) at the
Nos2 promoter is not where we and others suspected (Farlik
et al., 2010; Kleinert et al., 2004), so our understanding of
transcription binding sites to other promoters may also require
revision.
We describe here the mechanism for the interaction of ISGF3
andNF-kBat theNos2 and Il6 promoters and present indications
that the synergy between these transcription factors might also
take place, with subtle differences in mechanism, at a number
of other promoters. It is likely that variations of the mechanismCell Reports 12, 300–312, July 14, 2015 ª2015 The Authors 309
apply also to interactions between other transcription factors.
The ISGF3 complex is not the only transcription factor to interact
extensively with NF-kB. An in-depth, ChIP-seq-based analysis
of virus-infected cells has shown that IRF3 also interacts with
NF-kB (Freaney et al., 2013). We suggest that the mechanism
we uncovered may represent a widespread method for higher
eukaryotes to coordinate the activation of a number of genes,
not only in the innate immune response but also to enable rapid
and precise responses to changing environmental conditions or
to challenges posed by microorganisms.
EXPERIMENTAL PROCEDURES
Reagents
Recombinant IFN-bwas purchased from PBL and used at 250 U/ml. The inhib-
itor BI605906 (a gift from Phillip Cohen) was used at 10 mM.
Bacteria and Infection
Growth of Listeria monocytogenes strain LO28 and infection of cells at MOI 20
was as described previously (Stockinger et al., 2002). Heat-killed Listeria was
generated by incubation for 20 min at 70C.
Mice and Cells
Mice were housed under specific pathogen-free (SPF) conditions. C57BL/6,
Stat1/ (Durbin et al., 1996) and Stat2/ (Park et al., 2000) mice in a
C57BL/6 genetic background were sacrificed between 7–10 weeks of age.
BMDMs were obtained by culture of bone marrow in L-cell-derived colony-
stimulating factor 1 (Stockinger et al., 2002).
siRNA-Mediated Gene Knockdown
siRNAs (Menin, PTIP, WDR82, MED18, and CcnC; ON-TARGETplus, Dharma-
con, 6 pmol) or non-target control siRNA were mixed with Opti-MEM I medium
(Gibco) and transfected into BMDMs using Lipofectamine RNAiMAX (Invitro-
gen) according to the manufacturer’s instructions. 48 hr after transfection,
the mediumwas replaced by fresh medium without siRNA. Another 24 hr later,
cells were treated as described in the text and figure legends.
Chromatin Immunoprecipitation, Re-ChIP, and ChIP-Seq
ChIP re-ChIP experiments were performed as described previously (Wienerr-
oither et al., 2014). Antibodies are listed in Table S4, and primers for precipitate
amplification are listed in Table S5. Unless indicated otherwise, the proximal
Nos2 promoter was analyzed by amplification of a 251-bp fragment (gene
coordinates Chr11: 78920580–78920830). The proximal IL-6 promoter was
analyzed by amplifying a 198-bp fragment encompassing gene coordinates
Chr5: 30013385–30013582. 5–10 ng of DNA precipitate was used for the
generation of sequencing libraries using the KAPA library preparation kit for
Illumina systems. Libraries were quantified with a Bioanalyzer dsDNA 1000
assay kit (Agilent Technologies) and a qPCR next-generation sequencing
(NGS) library quantification kit (KAPA). Cluster generation and sequencing
was performedwith a HiSeq 2000 systemwith a read length of 100 nucleotides
according to the manufacturer’s guidelines (Illumina).
RNA Preparation and qPCR
RNA was isolated using a NucleoSpin RNA II kit (Macherey-Nagel) and quan-
tified using the NanoDrop method (ND1000, Peq lab). Primers for quantitative
real-time PCR are given in Table S5. mRNA expression data were normalized
to the housekeeping Gapdh gene and calculated relative to the respective un-
stimulated controls.
Western Blot
Western blots with CDK7 (sc-529) and CDK9 (sc-484) antibodies at a dilution
of 1:200 were performed as described previously (Kovarik et al., 1998). For
detection, the fluorescence-labeled secondary antibodies IRDye800 and
IRDye700 (LI-COR Biosciences) and an infrared imaging system (Odyssey,
LI-COR Biosciences) were used.310 Cell Reports 12, 300–312, July 14, 2015 ª2015 The AuthorsMicroarray Analysis
Total RNA fromBMDMs treated with heat-killed Listeria, IFN-b, or both for 2, 4,
and 8 hr was collected from three sets of independent experiments and puri-
fied with Trizol (Invitrogen) and an RNeasy mini kit (QIAGEN). Microarray anal-
ysis was performed by the Genomics Core of the Lerner Research Institute,
Cleveland Clinic, using 1 mg of total RNA and Illumina Mouse Ref-8 v2 expres-
sion bead chips. The datawere normalized by the quantilemethod. Expression
levels from untreated and treated cells were compared, and genes were
selected that increased >4-fold (differential p values, <0.05; average signals
in treated samples, >50).
ChIP-Seq Analysis
Quality-based trimming was performed at the 30 end of raw reads using the
‘‘trim-fastq.pl’’ script of the PoPoolation toolbox, where all trimmed reads
with a length of less than 40 bp were discarded. Quality-controlled reads
were mapped to the mouse genome (UCSC, mm10) using Bowtie (Langmead
et al., 2009), where all non-unique alignments were discarded. For post-
alignment filtering, reads mapped in a proper pair were selected, and PCR
duplicates were removed using SAMtools (Li et al., 2009). Peak calling was
performed using MACS (Zhang et al., 2008) version 2.0.10 with default param-
eters for NF-kB, STAT1, and STAT2 samples and the ‘‘–broad’’ parameter for
pol2 samples. A threshold of q < 0.1 was set for calling significant peaks, which
were annotated within the nearest 50 kb upstream of genes (including the gene
itself) using PeakAnalyzer (Salmon-Divon et al., 2010).
DNA Motif Analysis
Overlapping areas of enrichment are merged by MACS, resulting into much
wider peaks than the actual binding sites. With the PeakSplitter module of
the PeakAnalyzer tool, these enriched areas were sub-divided by accurately
partitioning enriched loci into finer resolution sets of individual binding sites.
These sequences were used for de novo motif analysis of the peak summit re-
gions where binding ismost probable. De novomotif finding was performed by
MEME (Bailey et al., 2006) on all of the significant ChIP-seq binding peaks for
NF-kB (HkL and IFNb treatment) and STAT1 (IFNb treatment) samples. The
parameter ‘‘minimum motif width’’ of MEME was set to 11 for NF-kB and 15
for STAT1 because this is their known motif width from the JASPAR (Sandelin
et al., 2004) database. The most significant de novo computed motifs were
compared with known motifs present in the JASPAR database with TOMTOM
(Gupta et al., 2007). Additionally, we scanned the promoter (50 kb) and gene
coordinates of Nos2 for the presence of NF-kB (relA), ISRE (STAT2:STAT1),
and GAS (STAT1) motifs, by using their appropriate position weight matrices
(PWM) from the JASPAR database. To the frequencies of each site of the
PWMs we added one (to avoid zero probabilities) and calculated the probabil-
ities of each of the four bases at each position. Sliding along each position of
the DNA sequence of the iNOS gene from 50 kb upstream to the end of the
gene, we calculated the fit of a position weight matrix starting at the respective
position by summing the log probabilities of the bases from the beginning to
the end of the PWM.We extracted fits exceeding a threshold that was specific
for each transcription factor.
GO Analysis
Enrichment of GO terms in 127 genes that had STAT1 and NF-kB-p65 binding
sites and greater than 2-fold enrichment of Pol II binding in the co-treated sam-
ple was computed using DAVID (Jiao et al., 2012). Among the significantly en-
riched GO terms (EASE score <0.05 according to a modified Fisher’s exact p
value), similar terms were groupedwith the ‘‘Functional Annotation Clustering’’
module of DAVID, which uses an algorithm to measure the relationship among
the annotated GO terms based on the degrees of their co-association genes.
Cooperativity between the Transcription Factors
For the transcription factors NF-kB_STAT1, we computed 2x2 contingency
tables according to the presence or absence of at least one peak within the
upstream 50-kb region of the focal gene (including the gene coordinates).
Furthermore, we divided this dataset into genes that show at least 2-fold syn-
ergistic enrichment in Pol II with double treatment versus single treatment
samples and those that do not. Various hypotheses were addressed with
2x2 contingency tables and tested with chi-square tests.
Pathway Analysis
The same list of 127 genes was analyzed for overrepresented KEGG pathways
using DAVID. Again, an EASE score of less than 0.05 was used as a threshold
to filter significantly overrepresented pathways.
Statistical Analysis
Differences betweenmean values for qPCR results of either mRNA expression
or ChIP experiments were analyzed by t test.
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